What are the criteria for diagnosing nephrotic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Nephrotic Syndrome

Nephrotic syndrome is defined by the presence of heavy proteinuria (≥3.5 g/day in adults or ≥40 mg/m²/h in children), hypoalbuminemia (<3.0 g/dL in adults or <2.5 g/dL in children), and edema. 1

Core Diagnostic Criteria

For Adults:

  1. Proteinuria:

    • ≥3.5 g/day or protein:creatinine ratio (PCR) >300-350 mg/mmol 2
    • This threshold was selected somewhat arbitrarily but remains the standard definition 3
  2. Hypoalbuminemia:

    • <3.0 g/dL 1
  3. Edema:

    • Typically periorbital (more noticeable in the morning)
    • Dependent pitting edema (more common later in the day) 2

For Children:

  1. Proteinuria:

    • ≥40 mg/m²/h or
    • Urine protein:creatinine ratio (UPCR) ≥2 g/g 1
    • Albustix 3+ on at least 3 occasions within 1 week 1
  2. Hypoalbuminemia:

    • ≤2.5 g/dL 1

    Note: While the 2021 KDIGO guideline suggested changing the definition to <3.0 g/dL for children, the KDOQI commentary recommends maintaining the traditional ≤2.5 g/dL threshold due to lack of evidence supporting this change. 1

Associated Features

These are commonly present but not required for diagnosis:

  1. Hyperlipidemia:

    • Hypercholesterolemia
    • Hypertriglyceridemia 1, 4
  2. Lipiduria 4

  3. Increased risk of thromboembolism:

    • Risk increases when serum albumin falls below 2.9 g/dL 1
    • Particularly high risk in membranous nephropathy 5
  4. Increased susceptibility to infections 6

Diagnostic Approach

  1. Quantify proteinuria:

    • 24-hour urine collection for total protein
    • Spot urine protein:creatinine ratio (PCR) or albumin:creatinine ratio (ACR)
    • In children, spot UPCR has replaced 24-hour collections due to good correlation and ease of collection 1
  2. Measure serum albumin:

    • Be aware of assay differences (bromocresol green vs. bromocresol purple) when interpreting results 1
  3. Evaluate for underlying cause:

    • Renal biopsy is typically indicated in adults 2, 5
    • In children, empiric steroid trial is often initiated first; biopsy is reserved for steroid-resistant cases 5
    • Investigate for secondary causes (diabetes, lupus, amyloidosis, infections, malignancies) 2, 5

Special Considerations

  1. Nephrotic syndrome without nephrotic-range proteinuria:

    • Can occur when albumin synthesis is decreased (e.g., concurrent liver disease)
    • A steady state of renal protein excretion may be reached at <3.5 g/day despite severe defects in glomerular permeability 3
  2. Monitoring for complications:

    • Thromboembolism risk assessment
    • Lipid profile
    • Infection surveillance 6

Treatment Implications

The diagnosis of nephrotic syndrome often guides treatment decisions:

  • In children with presumed minimal change disease, glucocorticoids are first-line therapy 5
  • In adults, treatment depends on the underlying cause identified by biopsy 2
  • Edematous states in idiopathic nephrotic syndrome are an FDA-approved indication for prednisone 7

The diagnostic criteria are essential for determining when to initiate specific therapies, such as in membranous nephropathy where treatment is recommended when proteinuria persistently exceeds 4 g/day for at least 6 months despite conservative therapy 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.

Journal of the American Society of Nephrology : JASN, 2014

Research

[Prevention and management of complications in nephrotic syndrome].

Nihon rinsho. Japanese journal of clinical medicine, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.